Anti-HIV Agent
AssigneeFuso Pharmaceutical Industries, Ltd.
InventorsNobutaka Wakamiya, Katsuki Ohtani, Takashi Sakamoto, Hiroyuki Keshi, Yuichiro Kishi
Life of this patent
Estimating the term…
Abstract
Disclosed are anti-HIV agents which comprise a mannose binding protein (MBP) as an active component and are useful for effectively inhibiting progress of diseases state in and useful in therapy for individuals infected with human immunodeficiency virus (HIV). Also disclosed are a method for evaluating an anti-HIV activity of MBP comprising the step of culturing HIV infected cells under the presence of MBP.
Claims17
1-40. (canceled)
A method of treating a subject infected with HIV comprising administering to said subject a composition comprising mannan binding protein (MBP), in an amount effective to inhibit HIV.
Dependencies are inferred from the claim text.